Table 3.
Networking to understand the collaboration between the partner country involved in clinical trials or any point of COVID-19 vaccine development.
| Scheme | Country Name | No. of Clinical Trials | Vaccine Clinical Trials Partner Country |
|---|---|---|---|
| 1. | India | 15 | ARG, CHL, COL, CZE, DEU, ESP, FRA, ITA, NLD, PER, SWE, USA |
| 2. | Nepal | 1 | PEL, PRA, COL, DEU, DOM, PAN, PHL, POL, JAF |
| 3. | China | 59 | ECU, IDN, PAK, UZB |
| 4. | South Korea | 9 | - |
| 5. | Japan | 13 | - |
| 6. | Taiwan | 6 | VNM |
| 7. | Hong Kong | 2 | - |
| 8. | Vietnam | 3 | TWN |
| 9. | Thailand | 3 | - |
| 10. | Singapore | 3 | USA |
| 11. | Indonesia | 4 | CHN, ECU, PAK, UZB, BRA |
| 12 | Malaysia | 1 | BRA |
| 13. | Philippines | 2 | BEL, BRA, COL, DEU, DOM, ESP, FRA, GBR, NPL, PAN, POL, USA, GAF |
| 14. | Pakistan | 3 | ARG, CHL, CHN, ECU, IDN, MEX, RUS, UZB |
| 15. | United Arab Emirates | 3 | BHR, EGY, JOR |
| 16. | Bahrain | 1 | ARE, EJY, JOR |
| 17. | Azerbaijan | 1 | - |
| 18. | Uzbekistan | 1 | CHN, ECU, IDN, PAK |
| 19. | Kazakhstan | 2 | - |
| 20. | Russia | 13 | ARG, BLR, CHL, MEX, PAK |